Risk of colorectal cancer in patients with hematologic disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 15, Issue 11, 2000, Pages 1272-1276

  Kishida, Teruyuki ^a   Yonezawa, Masaoki ^a   Shibata, Yoshiaki ^a   Tanaka, Shu ^a   Shinozawa, Isao ^a   Hoshino, Tetsuo ^a   Tatsuguchi, Atsushi ^a   Feng, Li ^a   Sato, Jun ^a   Fujimori, Shunji ^a   Yoshida, Yutaka ^a   Sakamoto, Choitsu ^a   Kobayashi, Masafumi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Colon cancer; Hematologic disease; Rectal cancer

Indexed keywords

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ERYTHROCYTE APLASIA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0033664438     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2000.02348.x     Document Type: Article

References (35)

1. Second malignancies in patients with multiple myeloma
2. Second acute leukemia and other malignancies following treatment for Hodgkin's disease
3. Second malignant neoplasms complicating Hodgkin's disease: The National Cancer Institute experience
4. Multiple primary cancers in patients with malignant lymphoma
5. Gastrointestinal involvement of malignant lymphoma
6. Endoscopic diagnosis of lower intestinal lesions of leukaemia and malignant lymphoma
7. Genetic alterations during colorectal-tumor development
8. Identification of a chromosome 18q gene that is altered in colorectal cancers
9. A genetic model for colorectal tumorigenesis
10. Ras oncogene mutation in multiple myeloma
11. Oncogenes in multiple myeloma: Point mutation of N-ras
12. p53 and RAS gene mutations in multiple myeloma
13. Mutations of the p53 gene in human myeloma cell lines
14. p53 gene mutations in multiple myeloma are assosiated with advanced forms of malignancy
15. Proposals for the classification of the acute leukaemias: French-American-British Cooperative Group
16. Report of the committee on Hodgkin's disease staging classification
17. National Cancer Institute sponsered study of classification of non-Hodgkin's lymphomas
18. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival
19. Proposals for classification of the myelodysplastic syndromes
20. Polymyositis-dermatomyositis and malignant lesions: Does an association exist?
21. Prognostic factors and predictive signs of malignancy in adult dermatomyositis: A study of 32 cases
22. Risk of cancer in patients with dermatomyositis or polymyositis: A population-based study
23. Remission of pure red cell aplasia associated with non-thymic malignancy
24. Bile duct adenocarcinoma with Leser-Trelat sign and pure red blood cell aplasia
25. Acquired pure red cell aplasia associated with thyroid carcinoma: A case report
26. Carcinoma coexistent with malignant disorders of plasma cell
27. Aplastic anemia: Presence in human bone marrow of cells that suppress myelopoiesis
28. Inteferon-γ and tumor necrosis factor-α suppress both early and late stages of hematopoiesis and induce programmed cell death
29. Treatment of severe aplasic anemia
30. Late haematological complications in severe aplastic anemia
31. Evolution of acquired severe aplastic anemia to myelodysplasia and subsequent leukaemia adults
32. Malignant tumors occurring after treatment of aplastic anemia
33. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia
34. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone
35. Colorectal cancer in Japan-epidemiological characteristics of colon cancer and rectal cancer